February 21, 2020
The GreenFund – A new study has found that medicinal cannabis may be able to reduce the intensity of chronic pain in patients by as much as 30%. A new study conducted by Southern Cannabis Holdings (SCH) has found that medicinal cannabis may be a highly effective treatment option for patients suffering from chronic pain....
Read More
Applied cannabis research - mgc pharma
STOCKHEAD MGC (ASX:MXC) will conduct a head-to-head clinical study on severe intractable epilepsy in collaboration with Cannabis Access Clinics and Epilepsy Action Australia, a direct comparison assessing the efficacy of low-THC to 100 per cent CBD products when treating severe intractable epilepsy. Read more : Ethics body approves another clinical trial using MGC Pharma’s epilepsy drug
Read More